Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2, PHASE3
Sponsor: Canadian Cancer Trials Group
Condition: Lung Cancer
NCT04093167
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.